Literature DB >> 25320615

Adverse effects of psychotropic medications in children: predictive factors.

Ajit Ninan1, Shannon L Stewart2, Laura A Theall3, Shehan Katuwapitiya4, Chester Kam5.   

Abstract

OBJECTIVE: Despite limited information related to efficacy in children, psychotropic medications are commonly prescribed as a first-line treatment for a range of psychiatric diagnoses in children in a variety of clinical settings. Usage has increased over the past three decades. Although psychotropic medications are often effective at treating psychiatric symptoms, the risk of adverse effects (AE) in children is unclear. The current research seeks to identify the mental health characteristics of those children at highest risk of experiencing potential AE from psychotropic medications.
METHODS: Psychotropic medication monitoring checklists were used to record possible AE for 99 pediatric clients in a tertiary mental health residential treatment centre for the duration of one to eight weeks. Client characteristics, including the number of diagnoses and behavioural variables, were explored for predictive value of potential AE observed.
RESULTS: Results showed that the total number of potential AE was positively predicted by the number of DSM-IV categories diagnosed, as well as behavioural symptoms of impulsiveness and uncooperativeness.
CONCLUSIONS: The findings of this study indicate that the number of potential AE from psychotropic medications may be predictable based on client characteristics. Predicting this likelihood during initial assessment can be useful in directing and monitoring treatment, as well as preventing serious events related to medication use.

Entities:  

Keywords:  adverse effects; children; psychotropic medication monitoring checklist; residential care

Year:  2014        PMID: 25320615      PMCID: PMC4197522     

Source DB:  PubMed          Journal:  J Can Acad Child Adolesc Psychiatry        ISSN: 1719-8429


  27 in total

1.  Psychometric study of the Child and Adolescent Functional Assessment Scale: prediction of contact with the law and poor school attendance.

Authors:  K Hodges; C S Kim
Journal:  J Abnorm Child Psychol       Date:  2000-06

2.  Annotation: The use of psychotropic medications in children: an American view.

Authors:  Mark L Wolraich
Journal:  J Child Psychol Psychiatry       Date:  2003-02       Impact factor: 8.982

3.  Best practices: An initiative to curtail the use of antipsychotic polypharmacy in a state psychiatric hospital.

Authors:  Vijayalakshmy Patrick; Steven J Schleifer; Jeffry R Nurenberg; Kenneth J Gill
Journal:  Psychiatr Serv       Date:  2006-01       Impact factor: 3.084

Review 4.  Long-term treatment with atypical antipsychotics and the risk of weight gain : a literature analysis.

Authors:  Salvatore Gentile
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

5.  National trends in the use of psychotropic medications by children.

Authors:  Mark Olfson; Steven C Marcus; Myrna M Weissman; Peter S Jensen
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2002-05       Impact factor: 8.829

6.  Use of the Child and Adolescent Functional Assessment Scale (CAFAS) as an outcome measure in clinical settings.

Authors:  K Hodges; M M Wong; M Latessa
Journal:  J Behav Health Serv Res       Date:  1998-08       Impact factor: 1.505

Review 7.  A theoretical approach to medication adherence for children and youth with psychiatric disorders.

Authors:  Alice Charach; Tiziana Volpe; Katherine M Boydell; Robin E Gearing
Journal:  Harv Rev Psychiatry       Date:  2008       Impact factor: 3.732

8.  Psychotropic medication monitoring checklists: use and utility for children in residential care.

Authors:  Ajit Ninan; Shannon L Stewart; Laura Theall; Gillian King; Ross Evans; Philip Baiden; Al Brown
Journal:  J Can Acad Child Adolesc Psychiatry       Date:  2014-02

Review 9.  Evidence-based treatments in child and adolescent psychiatry: an inventory.

Authors:  Jon M McClellan; John Scott Werry
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2003-12       Impact factor: 8.829

10.  A pilot study of risperidone, olanzapine, and haloperidol in psychotic youth: a double-blind, randomized, 8-week trial.

Authors:  Linmarie Sikich; Robert M Hamer; Robert A Bashford; Brian B Sheitman; Jeffrey A Lieberman
Journal:  Neuropsychopharmacology       Date:  2004-01       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.